PTPA and neoplasm: On the other hand, one of the negative regulators of SphK activity, the Ser/Thr phosphoprotein phosphatase PP2A, is a tumor suppressor enzyme implicated in cell transformation of various cancers, including hepatocellular carcinoma [26] as well as many other cellular events [30–32].